In comparison, STAT5A shows favorable prognostic associations in breast cancer but detrimental effects in hematologic malignancies [5], whereas STAT5B appears predominantly tumor-suppressive across epithelial cancers and protective in B-cell lymphomas. This evidence concerns the gene STAT5A and breast carcinoma.